Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corporation (NMTC)
Filing Type: Form 8-K (Current Report)
Report Date: August 13, 2026
Reporting Period: Third fiscal quarter ended June 30, 2026
Context: The filing serves to announce the issuance of a press release detailing financial results for the specified quarter. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references the existence of financial results in an attached press release (Exhibit 99.1) but does not contain the specific numerical data within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release by the Company but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 13, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates which are absent from this cover document.
- Check for any forward-looking statements or guidance updates contained within the referenced press release.
- Confirm the liquidity position and cash burn rate as of June 30, 2026, from the full financial disclosure.